Fidelity Investments
RARE icon

Fidelity Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$94.7M Buy
2,604,588
+2,223,166
+583% +$80.8M 0.01% 1141
2025
Q1
$13.8M Sell
381,422
-14,562
-4% -$527K ﹤0.01% 1801
2024
Q4
$16.7M Sell
395,984
-241,837
-38% -$10.2M ﹤0.01% 1788
2024
Q3
$35.4M Sell
637,821
-9,797
-2% -$544K ﹤0.01% 1511
2024
Q2
$26.6M Sell
647,618
-134,414
-17% -$5.52M ﹤0.01% 1547
2024
Q1
$36.5M Sell
782,032
-210,919
-21% -$9.85M ﹤0.01% 1437
2023
Q4
$47.5M Sell
992,951
-34,834
-3% -$1.67M ﹤0.01% 1312
2023
Q3
$36.6M Buy
1,027,785
+195,108
+23% +$6.96M ﹤0.01% 1361
2023
Q2
$38.4M Sell
832,677
-171,347
-17% -$7.9M ﹤0.01% 1375
2023
Q1
$40.3M Sell
1,004,024
-75,050
-7% -$3.01M ﹤0.01% 1338
2022
Q4
$50M Buy
1,079,074
+99,295
+10% +$4.6M 0.01% 1253
2022
Q3
$40.6M Sell
979,779
-178,463
-15% -$7.39M ﹤0.01% 1329
2022
Q2
$69.1M Sell
1,158,242
-97,282
-8% -$5.8M 0.01% 1119
2022
Q1
$91.2M Sell
1,255,524
-35,855
-3% -$2.6M 0.01% 1105
2021
Q4
$109M Buy
1,291,379
+130,394
+11% +$11M 0.01% 1067
2021
Q3
$105M Buy
1,160,985
+286,371
+33% +$25.8M 0.01% 1086
2021
Q2
$83.4M Sell
874,614
-2,900
-0.3% -$277K 0.01% 1200
2021
Q1
$99.9M Sell
877,514
-193,985
-18% -$22.1M 0.01% 1066
2020
Q4
$148M Sell
1,071,499
-98,600
-8% -$13.6M 0.01% 868
2020
Q3
$96.2M Sell
1,170,099
-272,003
-19% -$22.4M 0.01% 923
2020
Q2
$113M Sell
1,442,102
-333,608
-19% -$26.1M 0.01% 828
2020
Q1
$78.9M Sell
1,775,710
-47,664
-3% -$2.12M 0.01% 847
2019
Q4
$77.9M Sell
1,823,374
-260,247
-12% -$11.1M 0.01% 1018
2019
Q3
$89.1M Sell
2,083,621
-207,667
-9% -$8.88M 0.01% 934
2019
Q2
$145M Sell
2,291,288
-226,458
-9% -$14.4M 0.02% 769
2019
Q1
$175M Sell
2,517,746
-429,178
-15% -$29.8M 0.02% 698
2018
Q4
$128M Sell
2,946,924
-380,457
-11% -$16.5M 0.02% 742
2018
Q3
$254M Sell
3,327,381
-131,704
-4% -$10.1M 0.03% 583
2018
Q2
$266M Sell
3,459,085
-485,897
-12% -$37.4M 0.03% 553
2018
Q1
$201M Buy
3,944,982
+303,061
+8% +$15.5M 0.02% 681
2017
Q4
$169M Sell
3,641,921
-15,287
-0.4% -$709K 0.02% 761
2017
Q3
$195M Sell
3,657,208
-147,017
-4% -$7.83M 0.02% 694
2017
Q2
$236M Sell
3,804,225
-2,306,402
-38% -$143M 0.03% 615
2017
Q1
$414M Buy
6,110,627
+227,802
+4% +$15.4M 0.05% 389
2016
Q4
$414M Sell
5,882,825
-30,250
-0.5% -$2.13M 0.06% 370
2016
Q3
$419M Buy
5,913,075
+65,292
+1% +$4.63M 0.06% 373
2016
Q2
$286M Buy
5,847,783
+6,152
+0.1% +$301K 0.04% 519
2016
Q1
$370M Buy
5,841,631
+18,689
+0.3% +$1.18M 0.05% 389
2015
Q4
$653M Buy
5,822,942
+22,946
+0.4% +$2.57M 0.09% 232
2015
Q3
$559M Buy
5,799,996
+419,169
+8% +$40.4M 0.08% 268
2015
Q2
$551M Buy
5,380,827
+48,044
+0.9% +$4.92M 0.07% 309
2015
Q1
$331M Buy
5,332,783
+551,363
+12% +$34.2M 0.04% 474
2014
Q4
$210M Buy
4,781,420
+187,180
+4% +$8.21M 0.03% 653
2014
Q3
$260M Buy
4,594,240
+85,347
+2% +$4.83M 0.04% 533
2014
Q2
$125M Buy
4,508,893
+908,405
+25% +$25.1M 0.02% 881
2014
Q1
$85.1M Buy
+3,600,488
New +$85.1M 0.01% 1068